PRIMARY OBJECTIVE:
I. To demonstrate the effectiveness of a clinical oncology pharmacist in the outpatient infusion center through education, and the identification and correction of medication related problem (MRP)s.
SECONDARY OBJECTIVE:
I. To evaluate overall patient and staff satisfaction with the added clinical oncology pharmacy education.
EXPLORATORY OBJECTIVE:
I. Estimate the cost avoidance utilizing the pharmacy services provided in the prospective trial.
OUTLINE:
PHASE I: Patients' medical records are reviewed.
PHASE II: Patients receive pharmacist-led education on antineoplastic therapies including what to expect during infusion, general drug facts, common adverse effects, side effect management, and when to contact provider.
After completion of study, patients are followed up periodically.
